Skip to main content

Table 3 ME/CFS symptom characteristics

From: Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients

Age of diagnosis (Years [Mean ± SD])   26.70 ± 12.75
Disease duration (Years [Mean ± SD])   17.70 ± 14.95
Infectious onset, n (%)   8 (80.0%)
Cognitive difficulties Yes 10 (100%)
No 0 (0.0%)
Pain Yes 10 (100%)
No 0 (0%)
Sleep disturbances Yes 10 (100%)
No 0 (0%)
Sensory disturbances Yes 9 (90.0%)
No 1 (10.0%)
Immune disturbances Yes 9 (90.0%)
No 1 (10.0%)
Gastrointestinal disturbances Yes 9 (90.0%)
No 1 (10.0%)
Cardiovascular disturbances Yes 8 (80.0%)
No 2 (20.0%)
Respiratory disturbances Yes 8 (90.0%)
No 2 (20.0%)
Thermostatic instability Yes 10 (100%)
No 0 (0%)
Urinary disturbances Yes 5 (50.0%)
No 5 (50.0%)
  1. ME Myalgic encephalomyelitis, CFS chronic fatigue syndrome, SD standard deviation, n number